Conclusions—Bone marrow stem cell mobilization with subcutaneous G-CSF is safe but did not lead to further improvement in ventricular function after acute myocardial infarction compared with the recovery observed in the placebo group. (Circulation. 2006;1
Conclusions—Bone marrow stem cell mobilization with subcutaneous G-CSF is safe but did not lead to further improvement in ventricular function after acute myocardial infarction compared with the recovery observed in the placebo group. (Circulation. 2006;1
结论：与对照组相比，皮下注射G-CSF驱动骨髓干细胞具有安全性，但并不改善急性心肌梗死后患者的心室功能。